Latest Breaking News On - University of south florida research foundation inc - Page 1 : comparemela.com

Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million

Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of south florida research foundation incExchange commissionAlzamend neuro incSecurities exchangeAlzamend neuroSecurities purchase agreementConvertible preferred stockPreferred sharesEach preferred shareCommon stockFloor priceConversion priceCurrent reportUnited states securitiesSecurities act

Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program

Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesAscendiant capital marketsSecurities exchangeUniversity of south florida research foundation incExchange commissionAlzamend neuro incAlzamend neuroInvestor relationsSouth florida research foundationSecurities actSecurities exchange act

Alzamend Neuro Receives FDA Study May Proceed Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients | Region

ATLANTA (BUSINESS WIRE) Dec 11, 2023

United statesStephan jackmanSecurities exchangeAlzamend neuro incExchange commissionAmerican psychiatric associationDrug administrationUniversity of south florida research foundation incChief executive officerStudy may proceedNew drug applicationMayo clinicSouth florida research foundationSecurities actSecurities exchange actAlzamend neuro

Alzamend Neuro Regains Compliance with Nasdaq s Minimum Bid Price Requirement -November 16, 2023 at 08:01 am EST

Alzamend Neuro, Inc. , an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease , bipolar disorder , major depressive.

United statesUniversity of south florida research foundation incAlzamend neuro incExchange commissionSecurities exchangeAlzamend neuroListing qualifications staffNasdaq stock marketNasdaq listing ruleBid priceMinimum bid price requirementCompliance noticeMarket valueListed securitiesNasdaq capital marketSouth florida research foundation

Alzamend Neuro, Inc (ALZN) Stock Price | Stock Quote Nasdaq

Alzamend Neuro, Inc. (ALZN.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Alzamend Neuro, Inc. | Nasdaq: ALZN | Nasdaq

United statesUniversity of south florida research foundation incAlzamend neuro incAlzamend neuroSouth florida research foundationNc quotesTock quote